Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03825458

Creation of a Cohort for the Quantitation and Characterization of Circulating Viral RNAs as a New Biomarker of Hepatitis B Functional Cure.

Status
Recruiting
Phase
Study type
Observational
Enrollment
3,500 (estimated)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The " CirB-RNA " cohort aims to create a biological collection associated with clinical and biological data from patients with hepatitis B infection. This project is part of a much larger program that aims to characterize and quantify circulating viral RNAs as a possible new biomarker of hepatitis B functional cure.

Conditions

Interventions

TypeNameDescription
OTHERBlood samplingBlood sampling at each clinical follow-up visit.

Timeline

Start date
2019-02-25
Primary completion
2029-06-25
Completion
2029-06-25
First posted
2019-01-31
Last updated
2023-11-18

Locations

6 sites across 2 countries: France, Italy

Source: ClinicalTrials.gov record NCT03825458. Inclusion in this directory is not an endorsement.

Creation of a Cohort for the Quantitation and Characterization of Circulating Viral RNAs as a New Biomarker of Hepatitis (NCT03825458) · Clinical Trials Directory